21-46191371-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002340.6(LSS):c.2068-136A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 917,238 control chromosomes in the GnomAD database, including 7,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1407 hom., cov: 33)
Exomes 𝑓: 0.12 ( 6526 hom. )
Consequence
LSS
NM_002340.6 intron
NM_002340.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.21
Genes affected
LSS (HGNC:6708): (lanosterol synthase) The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 21-46191371-T-C is Benign according to our data. Variant chr21-46191371-T-C is described in ClinVar as [Benign]. Clinvar id is 1277484.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LSS | NM_002340.6 | c.2068-136A>G | intron_variant | ENST00000397728.8 | NP_002331.3 | |||
LSS | NM_001001438.3 | c.2068-136A>G | intron_variant | NP_001001438.1 | ||||
LSS | NM_001145436.2 | c.2035-136A>G | intron_variant | NP_001138908.1 | ||||
LSS | NM_001145437.2 | c.1828-136A>G | intron_variant | NP_001138909.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LSS | ENST00000397728.8 | c.2068-136A>G | intron_variant | 1 | NM_002340.6 | ENSP00000380837.2 |
Frequencies
GnomAD3 genomes AF: 0.127 AC: 19365AN: 152070Hom.: 1409 Cov.: 33
GnomAD3 genomes
AF:
AC:
19365
AN:
152070
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.119 AC: 91314AN: 765050Hom.: 6526 AF XY: 0.118 AC XY: 46860AN XY: 395956
GnomAD4 exome
AF:
AC:
91314
AN:
765050
Hom.:
AF XY:
AC XY:
46860
AN XY:
395956
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.127 AC: 19373AN: 152188Hom.: 1407 Cov.: 33 AF XY: 0.120 AC XY: 8966AN XY: 74412
GnomAD4 genome
AF:
AC:
19373
AN:
152188
Hom.:
Cov.:
33
AF XY:
AC XY:
8966
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
167
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 28, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at